Skip to content
Search

Latest Stories

FEATURE: Saving the skin’s bricks and mortar

Consultant dermatologist Rishika Sinha shares her expertise with community pharmacy teams on how they can help themselves as well as their patients suffering from lockdown and coronavirus-related skincare problems…


Our hands have become another casualty of the pandemic. Repeated hand-washing with hot water laced with anti-microbial foaming soaps for a prolonged period (I can hear ‘Happy Birthday’) has led to erosion of the bricks and mortar of our skin.

Hand-hygiene products damage the skin by causing denaturation of the stratum corneum (the thinnest and topmost past of the epidermis) and depletion of the lipid barrier, leading to increased dryness and irritation.

It is well known that products that contain sodium laurel sulphate (SLS) have been shown to contribute to irritant dermatitis by inducing a dose-related increase in transepidermal water loss (TEWL).

Despite this, it continues to be widely present in hand wash formulations as it is an effective surfactant, hence lowering the surface tension between ingredients to allow for effective cleansing.

Researchers from Germany tested 1,600 patients with SLS irritancy and found that 42 per cent of the patients tested developed an irritant reaction. Another study found that the warmer the water used, the more irritating SLS will be. Consider these two factors and it would appear that hand dermatitis is an almost inevitable consequence of this infection.

There are ways to mitigate the irritation that hand dermatitis can cause, whilst obliging to the hand-hygiene measures required in Covid-era. This may include the selection of gentler and less irritating hand-hygiene products. It may also be possible to avoid certain practices that increase the risk of irritation as well as using moisturising skin care products following hand cleansing.

iStock 1215997407 'Frequent and copious application of moisturiser is the most effective way of combating dry skin'

Lesser irritating cleansing products have been in circulation for many years as healthcare workers (HCW) have long suffered the effects of over washing on their hands.

Products containing benzalkonium chloride 0.1 per cent and chlorhexidine dihydrochloride 0.1 per cent in a liquid paraffin base are gentle and effective and have been the recommended products for HCW with hand dermatitis.

Avoiding certain practices to increase the risk of irritation may be tricky with restricted items available in workplaces, however if you can make a choice then I would recommend products free of SLS as traditional soap-based products can be associated with skin damage, dryness and irritation. Alcohol based hand gels containing humectants (products that retain moisture) are associated with better use by HCW.

Hand dermatitis aside, increased time spent indoors has had a significant impact on the skin in a multi-factorial setting. The combination of indoor heating and reduced ventilation can lead to drier air indoors.

This can cause dryness on the skin which can manifest as tightness, scaling, flaking and general irritation. This may provoke itchiness which can lead to scratching, and the classical itch-scratch cycle can begin.

Steps can be taken to reduce this irritation such as using SLS free body washes and frequently applying moisturisers. Ointments are preferable to lotions due to the increased lipid content, which is more effective at hydrating the skin, compared to lotions which are water-based products and are much thinner in consistency.

A classic mistake I have noted when using ointments is using an inadequate quantity. Frequent and copious application of moisturiser is the most effective way of combating dry skin.

Dryness can compound pre-existing skin conditions such as eczema and psoriasis. There are a variety of over-the-counter products that can help with the symptoms of dryness such as fragrance-free, hypoallergenic cleansers and fragrance-free emollient creams.

Acne or ‘maskne’ has also become a recognized phenomenon of the pandemic due to the number of people wearing largely synthetic, water-resistant masks for an extended period of time.

The masks can occlude our skin, increase congestion and lead to the formation of spots, particularly around the chin and jawline. Cleansers containing salicylic acid are excellent at dissolving keratin (the dead layer of skin that gets trapped in our pores) and can lead to a reduction in the number of spots.

Benzyl peroxide can also be used to destroy the bacteria that is associated with acne. It can take a few weeks to work, but is available in many different forms: creams, lotions, washes and gels.

Topical retinols can also reduce the number of spots by reducing pore size and cell turnover. It can take many weeks to work and occasionally the acne may worsen before it improves.

Dr Rishika Sinha is a consultant dermatologist and British Skin Foundation spokesperson.

More For You

How to leverage data to drive pharmacy growth

Adele Curran, chief operating officer at Real World Analytics (RWA) Pharmacy.

Pharmacy challenges: How data can help spot the ‘elephant in the room’

Adopting new technologies is vital for moving pharmacy forward — but are you fully harnessing the data these tools generate?

“Being able to utilise, manage, and interpret the data these technologies provide can help add more value to your business,” said Adele Curran, chief operating officer at Real World Analytics (RWA) Pharmacy, while speaking at the recent Pharmacy Business Conference.

Keep ReadingShow less
Branded OTC products can boost pharmacy revenue and promote self-care, says PAGB CEO

Michelle Riddalls

How branded OTC products can help struggling community pharmacies - PAGB chief explains

Branded over-the-counter (OTC) products could play a vital role in promoting self-care and supporting the sustainability of community pharmacies, said Michelle Riddalls, CEO of PAGB – the consumer healthcare association – during the recent Pharmacy Business Conference.

Riddalls emphasised that OTC medicines not only enable consumers to better manage their health through self-care but also offer pharmacies an opportunity to increase revenue, particularly during a time of mounting financial pressure.

Keep ReadingShow less
How Peptides Are Transforming Modern Drug Development

Modern Drug Development

How Peptides Are Transforming Modern Drug Development

The pharmaceutical industry is rapidly evolving, embracing new technologies and methodologies. Peptides are emerging as a crucial component in this transformation, offering innovative solutions to drug development. This shift is not only reshaping how drugs are discovered but also enhancing their efficacy and safety.

In recent years, the pharmaceutical landscape has undergone significant changes, driven by advancements in technology and scientific understanding. One of the most promising areas of innovation is the use of peptides in drug development. These short chains of amino acids have proven to be versatile tools, capable of targeting specific cells or molecules with high precision. In this context, certain bpc 157 peptide research peptides have been highlighted for their potential applications in various therapeutic areas, showcasing the promise that peptides hold for modern pharmaceutical studies.

Keep ReadingShow less
Off-patent medicines could save NHS millions—but only if UK remains attractive to suppliers - BGMA

BGMA chief executive Mark Samuels urges government to back off-patent medicines ahead of Life Sciences Plan release.

UK risks losing millions in NHS savings without stronger support for generics - BGMA

The British Generic Manufacturers Association (BGMA) has called on the government to create a more supportive environment for the generics and biosimilars sector, warning that the UK risks missing out on significant NHS savings arising from new off-patent medicines.

According to the BGMA, 31 medicines are due to lose patent protection between January and June 2025, with a further 28 set to follow in the second half of the year.

Keep ReadingShow less
Support for generic medicines manufacturers key to affordable healthcare- Teva UK director

Teva UK sounds alarm on accelerating consolidation of critical generic medicines

Photo credit: gettyimages

Exclusive: Teva UK calls for inclusion of generic manufacturers in policy talks

A healthy and vibrant generics marketplace supports not only patients but also contributes billions of pounds in savings to the drugs bill. However, growing pressures on generic medicine manufacturers could threaten this vital part of the healthcare ecosystem, warns Ryan Ruscoe, senior director of generics and OTC at Teva UK.

Speaking exclusively to Pharmacy Business, Ruscoe stressed the urgent need to address supply chain vulnerabilities, particularly for critical generic medicines.

Keep ReadingShow less